Reporting of Respiratory Virus-Associated Pediatric Mortalities

November 16, 2026

Dear Colleague:

Every year, respiratory viruses like influenza (flu), SARS-CoV-2 (COVID-19), and respiratory syncytial virus (RSV) lead to a significant number of hospitalizations and deaths. It is important to quantify and understand the burden and nature of severe outcomes from these respiratory viruses, especially in pediatric populations in Virginia. These public health surveillance efforts can help us better understand which populations may be at higher risk of severe outcomes and can ultimately inform prevention strategies.

Beginning October 26, 2026, the Virginia Department of Health (VDH) requests that physicians (including medical examiners) and persons in charge of a medical facility voluntarily report deaths in individuals less than 18 years of age following an illness clinically compatible with COVID-19 or RSV infection. This request for voluntary reporting is being conducted in accordance with the authority outlined in the Virginia Regulations for Disease Reporting and Control, 12 VAC 5-90-80, Section H. These deaths can be reported to your local health department through normal disease reporting processes.

Influenza-associated pediatric mortality has been reportable in Virginia since 2007, and there are no changes to reporting of this condition.

Respiratory illness activity in Virginia is currently low but is trending up. Please continue to encourage your patients and healthcare colleagues to be up to date on recommended respiratory virus immunizations. It is not too late to receive the seasonal flu vaccine, which is recommended for all people over six months of age. COVID-19 vaccines are available for everyone aged six months and older and are especially recommended for those at high risk of severe disease, including older adults, infants, and during pregnancy. RSV immunizations help protect older adults, infants (via maternal RSV vaccination or infant immunization with RSV monoclonal antibody), and young children from severe RSV disease.

Please visit the Respiratory Diseases in Virginia webpage for additional resources and data products. Specific information is available to address Preventing Transmission of Respiratory Viruses in Healthcare Settings.

Thank you for your continued partnership in keeping Virginians safe from respiratory illnesses.

Sincerely,

B. Cameron Webb, MD, JD

State Health Commissioner

Updates on Measles and Preparing for Upcoming Holiday Travel

November 13, 2026

Dear Colleague,

This letter provides updates on measles activity in Virginia and recommendations on preparing for upcoming holiday travel.

VDH urges clinicians to support patients to take appropriate precautions to protect their health as holiday travel begins.

As of November 12, 2026, the Virginia Department of Health (VDH) has reported 185 cases of measles in 2026. While measles activity within Virginia has remained low over the past several months, six (6) cases have been recently reported in Charlotte County in the Piedmont Health District and Augusta County in the Central Shenandoah Health District. It is possible that there are more cases than those that have been reported to public health. The VDH measles webpage is updated on Tuesdays and Thursdays and it continues to be the best source of information about measles in Virginia.

As travel increases during the upcoming holiday season, this could result in further increases in measles activity in Virginia. Measles activity is high across many areas in the United States and the world, and large outbreaks are ongoing in nearby states. Traveling to areas with known measles transmission poses a risk to the traveler, their family, and community members if they are not protected against measles. Localities with measles, mumps, and rubella (MMR) vaccination coverage below 95% are at highest risk for outbreaks.

VDH encourages all clinicians in Virginia to:

On behalf of the entire VDH team, thank you for your partnership, dedication, and determination in keeping Virginians safe and healthy.

Sincerely,

B. Cameron Webb, MD, JD

State Health Commissioner

CMS Finalizes Separate NPI and Provider-Based Attestation Requirements for Off-Campus Hospital Outpatient Departments

  • On November 6, 2026, CMS will publish the CY 2027 OPPS/ASC final rule, which implements Section 6225 of the Consolidated Appropriations Act, 2026 (CAA 2026).
  • Starting January 1, 2028, Medicare will not pay under the OPPS (or under the PFS-equivalent “applicable payment system” for non-excepted departments) for items or services furnished by an off-campus outpatient department of a hospital unless: (1) the department has its own National Provider Identifier (NPI); (2) the hospital has submitted an initial provider-based attestation for the department; and (3) the hospital later submits a subsequent attestation on time.
  • For every off-campus department already furnishing services on or before January 1, 2028, the initial attestation must be submitted between January 1, 2026 and December 31, 2027. That window is open now.
  • Prior CMS provider-based determinations are not grandfathered. Departments approved before January 1, 2026 must submit a new attestation.
  • Noncompliance affects payment only for the specific off-campus department that fails the requirements, not all of the hospital’s OPPS payments.

Hospitals have long been required to comply with the provider-based rules at 42 CFR 413.65, but since 2000 a hospital has had to submit an attestation only if it wanted a CMS determination of provider-based status. Payment was never conditioned on verifying compliance. Section 6225 changes that by adding new paragraph (23) to Section 1833(t) of the Social Security Act. It ties OPPS payment for off-campus departments to a separate NPI and a provider-based attestation, and it directs CMS to set up an attestation process with review through site visits, remote audits, or other means.

1. Which departments are covered

  • An “off-campus outpatient department of a provider” is a department of a provider that is not on the main provider’s campus or within 250 yards of a remote location of a hospital (new definition at 42 CFR 413.65(a)(2)). Departments within 250 yards of a remote location are not subject to the NPI or attestation requirements.
  • Distance from a remote location is measured with straight-line measurements, generally from any point of the remote location facility that provides patient care. Non-structural features such as awnings or walkway overhangs are not acceptable measuring points.
  • A “department” is defined by its physical address as listed in PECOS, including suite or floor number where applicable. One off-campus address equals one department and needs one NPI, even if it offers multiple service lines (for example, laboratory and radiology).
  • Facilities listed at 42 CFR 413.65(a)(1)(ii), for which CMS historically has not made provider-based determinations, are covered if they meet the definition. CMS said it may look for ways to reduce burden for these facilities in subregulatory guidance.
  • There is no de minimis exception. A department that does not seek payment under the OPPS or the applicable payment system, however, is not required to comply.

2. Who is excluded

  • Critical Access Hospitals (excluded from the OPPS; the regulation text expressly excludes them).
  • Provider-based Rural Health Clinics, which are “provider-based entities,” not “departments of a provider.”
  • Hospitals in the AHEAD Model (such as Maryland hospitals), which are not paid under Section 1833(t).
  • Indian Health Service and Tribal facilities (42 CFR 413.65(m)) and certain FQHCs and look-alikes (42 CFR 413.65(n)).
  • Remote locations of a hospital themselves, which provide inpatient services and are not off-campus outpatient departments.

3. Separate NPI requirement (new 42 CFR 419.23)

  • Each off-campus department must obtain its own NPI by January 1, 2028, and its items and services must be billed under it.
  • Before submitting an attestation, the hospital must obtain the department NPI and update its enrollment record in PECOS.
  • CMS is changing claims processing so that a claim can carry multiple NPIs: the hospital’s claim-level NPI plus service-line NPIs for services furnished during the day. Detailed billing guidance is still to come.

4. Attestation requirement and timing (new 42 CFR 413.65(b)(6))

Department status Initial attestation deadline
Furnishing services on or before January 1, 2028 Submit between January 1, 2026 and December 31, 2027
Begins furnishing services after January 1, 2028 Submit within the 2 years before furnishing billed services
Subsequent attestation Interval set by CMS, no more than 5 years after the date the prior attestation was submitted; details to be set in 2028 rulemaking
  • A timely initial attestation satisfies the requirement even if CMS has not issued a provider-based determination before the department starts furnishing services (new 42 CFR 419.23(c)).
  • CMS will use a standardized national attestation form submitted through a centralized electronic system, replacing MAC-specific templates. Until that system is live, hospitals may submit attestations to their MAC under the current process at 42 CFR 413.65(b)(3), and those submissions count toward Section 6225.
  • Supporting documentation does not have to be submitted with the attestation, but hospitals must keep it and produce it on request, generally within a period not to exceed 60 days.
  • A department must be added to the hospital’s enrollment record through the Form CMS-855A process before attesting, and CMS urged hospitals to build that time into their planning.

5. Review, documentation, and oversight

  • CMS and its contractors, including MACs, will screen every attestation for completeness and consistency with PECOS. Flagged attestations will receive targeted documentation review.
  • CMS expects to prioritize extended reviews for hospitals with a single off-campus department and to review a random sample for hospitals with multiple departments. A deficiency found in the sample may lead CMS to expand that review to the hospital’s other departments.
  • Hospitals should be ready to document location (distance), licensure, clinical integration, financial integration, public awareness, hospital outpatient department obligations under 42 CFR 413.65(g) (including EMTALA, site-of-service billing, and beneficiary notice of coinsurance liability), ownership and control (100% ownership), administrative integration (including an organizational chart), and management contract requirements.
  • CMS will issue written notice of the outcome, with the basis for any adverse determination and appeal rights. Hospitals with minor deficiencies may get an informal chance to correct them. Failure to provide requested documentation on time may lead to a noncompliance finding and payment recovery under 42 CFR 413.65(k).

The attestation window is already open and closes December 31, 2027. The steps below are grouped into three phases. Because the rule was finalized in November 2026, “groundwork” that ideally would have been done in 2024 and 2025 is now catch-up work and should be finished right away.

Phase 1: Groundwork (2024–25 work; complete immediately if not done)

  1. Build a department inventory. List every outpatient location by the exact address in PECOS, including suite and floor. Mark each as on-campus, within 250 yards of a remote location, or off-campus. Confirm distances with straight-line measurements from patient-care buildings.
  2. Check enrollment. Make sure every off-campus department appears correctly on the hospital’s Form CMS-855A enrollment. File any missing locations now, because the department must be enrolled before you can attest.
  3. Run a provider-based gap assessment. Test each department against 42 CFR 413.65(d), (e), (g), and (h): licensure, clinical, financial, and administrative integration, public signage and identification, 100% ownership and control, EMTALA, beneficiary notices, and any management contracts. Fix gaps before you sign.
  4. Assemble the documentation file. Gather organizational charts, privileging records, general ledger and cost report support, licenses, signage photos, notices, and management contracts so you can respond within the roughly 60-day window if CMS asks.

Phase 2: Attestations (January 1, 2026 – December 31, 2027)

  • Get the NPIs. Obtain one organizational NPI for each off-campus address and update PECOS before attesting.
  • Plan and make the filing. Decide whether to file with your MAC under the current process or wait for the centralized system. Waiting carries deadline risk; do not let the December 31, 2027 date slip. Confirm who your authorized official in PECOS is, and line up written authorization for any consultant acting for you.
  • Re-attest departments that already have CMS determinations. Prior approvals do not count, and attestations submitted before January 1, 2026 do not satisfy the requirement.
  • Prepare billing systems. Work with revenue cycle and clearinghouse vendors to report department NPIs on claims, and watch for CMS billing guidance. Test claims well before January 1, 2028.
  • Talk to commercial and Medicare Advantage payers. New NPIs can cause prior authorization, credentialing, coordination of benefits, and secondary claim problems. Load the new NPIs with payers in advance.

Phase 3: Go-live and ongoing compliance (January 1, 2028 and after)

  1. Go live on department NPIs. Monitor early claims for denials tied to a specific department or NPI.
  2. Run new departments through the process. Any department opening after January 1, 2028 must be assigned an NPI, enrolled, and attested within the 2 years before its first billed service.
  3. Calendar the subsequent attestation. It is due no more than 5 years after each attestation submission date, and watch the CY 2028 rulemaking for the final cadence.
  4. Expect audits.
  • Release of the final standardized attestation form and the centralized electronic submission system.
  • CMS billing and claims instructions for department NPIs.
  • CY 2028 OPPS rulemaking on the subsequent attestation.

If you have any questions or need further guidance regarding this matter, please contact Emily W. G. Towey at [email protected].

Click here for a full PDF of the alert.

The information contained in this alert is for general educational purposes only. It is presented with the understanding that neither the author nor Hancock, Daniel & Johnson, LLC, is offering any legal or other professional services. Since the law in many areas is complex and can change rapidly, this information may not apply to a given factual situation and can become outdated. Individuals desiring legal advice should consult legal counsel for up-to-date and fact-specific advice. Under no circumstances will the author or Hancock, Daniel & Johnson, LLC. be liable for any direct, indirect, or consequential damages resulting from the use of this material.

Medical Society of Virginia Foundation Announces 2026 Shapiro-Konerding Women in Medicine Leadership Award Recipient

Richmond, Va. (Oct. 20, 2026) — The Medical Society of Virginia Foundation (MSVF) is proud to announce that Jaclyn B. Wiggins, MD of Charlottesville has been selected as the 2026 recipient of the Shapiro-Konerding Women in Medicine Leadership Award, which recognizes women physicians demonstrating exceptional leadership, innovation, mentorship, and service to medicine.  

Dr. Wiggins serves as Interim Associate Pediatric Residency Program Director, Associate Fellowship Program Director in Neonatal-Perinatal Medicine, and Assistant Professor of Pediatrics at the University of Virginia. 

“Dr. Wiggins exemplifies the vision of the Shapiro-Konerding Women in Medicine Leadership Fund through her exceptional integration of patient care, medical education, and systems-level leadership,” said the award selection committee. “Her work to advance competency-based assessment, curriculum transformation, and AI-enabled precision education is shaping the future of physician training while improving outcomes for both learners and patients.” 

A recognized leader in medical education, Dr. Wiggins has led initiatives focused on improving trainee development and performance, including NIH- and AMA-supported projects and innovative feedback systems designed to enhance clinical reasoning and learner growth. Colleagues and trainees consistently recognize her collaborative leadership style, outstanding teaching, and dedication to fostering learning environments that balance high expectations with psychological safety. 

“Dr. Wiggins has rapidly emerged as one of the most promising leaders in academic medicine,” said Jonathan Swanson, MD, MSc, MBA, Professor of Pediatrics, Chief Quality Officer for Children’s Services, and Director of the Division of Neonatology at the University of Virginia. “She combines visionary thinking with humility, compassion, and an unwavering commitment to developing the next generation of physicians. Her innovations are transforming medical education, and her mentorship is making a lasting impact on trainees and colleagues alike.” 

Dr. Wiggins is a member of the Medical Society of Virginia and is actively involved with the Virginia Neonatal Perinatal Collaborative, where she contributes to the organization’s peri-viability project. 

About the Medical Society of Virginia Foundation 

The MSV Foundation (MSVF) advances opportunities for physicians to participate in health improvement efforts in Virginia by supporting programs and initiatives that equip physicians to best serve themselves, their patients and their communities. For more information, visit www.msv.org/foundation. 

The MSV Installs President Arturo Saavedra, MD, PhD as President at 2026 Annual Meeting

RICHMOND, Va. (Oct. 19, 2026) – Arturo Saavedra, MD, PhD, of Richmond, Virginia, was installed as the president of the Medical Society of Virginia (MSV) during the organization’s Annual Meeting held on October 18, 2026, in Roanoke. Dr. Saavedra currently serves as the executive vice president and provost for Virginia Commonwealth University. 

In his inaugural address, Dr. Saavedra emphasized that his presidency will be grounded in shared leadership and service to the profession. “As I look around this room, filled with some of the most dedicated physicians in Virginia, I am reminded that this is not my moment alone. This is our moment. Together, we will continue advancing medicine, mentoring future physicians, and serving the common good,” he said. 

As part of that focus, Dr. Saavedra framed Virginia’s physician workforce challenges as a patient-access issue, emphasizing that the data behind workforce shortages ultimately reflects real people and real barriers to care. “When we talk about the physician workforce, it is easy to make this a conversation about numbers—how many physicians we have, how many we need and where they practice,” he said. “But every one of those numbers eventually becomes a patient story.” 

Dr. Saavedra’s presidential platform will focus on strengthening Virginia’s physician workforce, reducing administrative burdens, and advancing solutions that improve timely access to care for patients across the Commonwealth. He noted that workforce shortages show up in everyday patient experiences: the parent trying to find a pediatric specialist, the older Virginian waiting months for an appointment, the rural patient driving an hour for care, and the physician whose day is increasingly consumed by downcoding, credentialing, or appeals issues instead of patient care. 

After graduating magna cum laude from Harvard College with a degree in Biological Sciences, Dr. Saavedra received a combined medical and doctoral degree from the University of Pennsylvania, with specialized training in pharmacology. He completed his residency training in internal medicine at the Brigham and Women’s Hospital, where he was also chief resident. He graduated from the Harvard Combined Dermatology Residency Training Program and completed his fellowship in dermatopathology. He also earned an MBA in entrepreneurial finance from the Babson College Graduate School of Business. 

Throughout the coming year, Dr. Saavedra will elevate his platform by keeping the connection between physician support and patient access at the center of MSV’s work. His leadership will underscore that strengthening the physician workforce is not only about supporting the profession, but also about ensuring Virginians can receive the care they need, when and where they need it. 

About the Medical Society of Virginia 

The Medical Society of Virginia (MSV) serves as the voice for more than 30,000 physicians, residents, medical students, PAs and PA students, representing all medical specialties in all regions of the Commonwealth. The association was founded in 1820 and is headquartered in Richmond, Virginia. MSV strives to advance high-quality healthcare and make Virginia the best place to practice medicine and receive care. 

The Medical Society of Virginia Foundation Recognizes Seven Outstanding Physicians

Richmond, Va. (Oct. 20, 2026) –The Medical Society of Virginia (MSV) Foundation announced the winners of their annual Salute to Service Awards at their Physicians Gala in Roanoke, Virginia on Saturday, October 18, 2026. Seven Virginia physicians are being recognized from across the Commonwealth for their outstanding service in six categories: Service to — the Profession, the Uninsured and Underinsured, by an Early Career Physician, a Medical Student or Resident Advancing Patient Safety and Quality Improvement, and Distinguished Medical School Faculty Service Award.  

The premiere award, Service to the Profession, has been given to Dr. Harry L. Gewanter, MD, FAAP, MACR, former president of the Medical Society of Virginia and the Richmond Pediatric Society. 

 

The 2025 Winners of the MSV Foundation’s Salute to Service Awards include: 

  • Guiliano Melki, MD, Emergency Medicine Residency, Virginia Commonwealth University, Service by a Medical Student or Resident  
  • Jordyn Griffin, MD, MS of Richmond, Service by an Early Career Physician 
  • Peter Kenneth O’Brien, MD, FACC of Lynchburg, Service for Advancing Patient Safety and Quality Improvement 
  • Bruce Lo, MD, FACEP of Old Dominion University, Service by a Distinguished Medical School Faculty Member 
  • Andrew Mihalek, MD of University of Virginia, Service by a Distinguished Medical School Faculty Member 
  • Bridget M. Bryer, MD of Charlottesville, Service to the Uninsured and Underserved 
  • Harry L. Gewanter, MD, FAAP, MACR of Richmond, Service to the Profession 

 

The MSV Foundation created the annual Salute to Service Awards in 2004 to recognize outstanding efforts of physicians, residents, and medical students who are dedicated to creating and nurturing a caring health promotion and disease prevention environment by providing service on behalf of patients everywhere.  

About the Medical Society of Virginia Foundation 

The MSV Foundation (MSVF) advances opportunities for physicians to participate in health improvement efforts in Virginia by supporting programs and initiatives that equip physicians to best serve themselves, their patients and their communities. For more information, visit www.msv.org/foundation. 

MSV Partners with Mduo

A one-sided negotiation is no negotiation at all.

Unfortunately, too many physicians are kept in the dark when it comes to knowing their true market value. Understanding compensation benchmarks, contract terms and career options empower doctors to better shape their income and careers for years to come.

That’s the power of Career Care AI.

The Medical Society of Virginia (MSV) has partnered with mduo to bring the doctors of Virginia the latest in career intelligence. With our new MSV Career Care Center, members benefit from personalized insights that are tailored specifically to your career stage — from residency to retirement.

“Physicians thrive on the latest insights and evidence,” said Melina Davis, Executive Vice President and CEO of MSV. “That’s why MSV is dedicated to putting the power of career intelligence in doctors’ hands.”

Knowing your worth means every Virginia physician now has the evidence needed to maximize your career.

Your member benefits include Virginia-specific salary insights, personalized compensation data, AI-powered contract analysis, early access to physician opportunities across Virginia and Career Care AI to help answer the professional questions that matter to you. Plus, MSV members can earn a $1,000 referral bonus when any physician they recommend is hired.

Log in to your Career Care Center → mduo.ai/virginia

2026 Nominating Committee Report

The Nominating Committee considered all eligible candidates for the upcoming term of office. The committee recommends the following slate for consideration by the society membership. 

MSV BOARD OF DIRECTORS 

Term 2026-2027/2028 


Officers (Elected for 1-year term)

President-Elect | Michele Nedelka, MD
Speaker | Atul Marathe, MD
Vice Speaker | Josh Lesko, MD

Directors (Elected for 2-year term)

District 2 John Sweeney, MD

District 2 Sharon Sheffield, MD

District 6 Daniel Pauly, MD

District 8 Marc Alembik, MD

District 10 Lauren Grawert, MD

District 10 Soheila Rostami, MD

Academic Peter Netland, MD

 

Directors (Elected for 1-year term)

MSV Foundation Lee Ouyang, MD

Resident Kira Dubester MD (UVA)

Medical Student Vignesh Senthilkumar (UVA)

Associate Directors (Elected for 2-year term)

District 2 Jessica Burgess, MD  

District 6 Mark Kleiner, MD  

District 8 Zerline Chambers-Kersey, MD 

District 10  Barbara Boardman, MD 

Academic Scott Strayer, MD (VCU) 

 

Associate Directors (Elected for 1-year term)

District 5 (at-large) Jacqueline Fogarty, MD

Resident Morgan Hopp, MD (Inova)   

Medical Student Russell Hawes, III (UVA) 

 

Virginia Delegation to the American Medical Association Term 2026-2027

Elected for a 2-year term
DELEGATES                                                                   

Thomas Eppes, Jr. MD

Joshua Lesko, MD

Lee Ouyang, MD

ALTERNATE DELEGATES

Mohit Nanda, MD

2026-2027 NOMINATING COMMITTEE

Elected for a 1-year term

District 1     Sterling Ransone, MD (Chair) 

District 2    Cynthia Romero, MD   

District 3    Tovia Smith, MD  

District 5     Pradeep Pradhan, MD  

District 6  Mark Kleiner, MD  

District 7     Claudette Dalton, MD  

District 8     Carol Shapiro, MD  

District 9     Abraham Hardee, DO  

District 10 Andrea Giacometti, MD  

Academic    Carolyn Burns, MD  

AMA Advisor  Clifford Deal, MD   

2024-2025 Former President Advisor  Joel Bundy, MD  

2025-2026 Former President Advisor  Mark Townsend, MD  

Electronic Death Registration System Update

As a result of HB156/SB194, effective July 1, 2026, physicians, APRNs, and PAs applying for initial licensure or renewing their licenses will be required to indicate whether they expect their scope of practice to include signing death certificates. If so, they must also attest that they have completed the online tutorial for the Electronic Death Registration System available on the Department of Health’s website.

Providers impacted by this change can meet the requirements of the bill by watching an 8-minute video on the Department of Health’s website here: https://www.vdh.virginia.gov/vital-records/electronic-death-registration-system/training/

The website also contains additional information and tutorials to help providers understand the Electronic Death Registration System and fulfill the training requirements.

Updates on Measles Outbreak and Vaccine Recommendations in Virginia

August 19, 2026

VDH Declares End to Measles Outbreak in Buckingham and Cumberland Counties

The Virginia Department of Health (VDH) recently announced the end of the 2026 measles outbreak in Buckingham and Cumberland Counties. The last confirmed outbreak-associated case was reported on June 29. An outbreak of measles is considered over after 42 days (two 21-day incubation periods) have passed without identifying a new case.

The outbreak resulted in 154 measles cases counted since May 5. All cases were in people who were not vaccinated or had an unknown vaccination status. Over a third of cases (38%) were in adults 18 years of age or older. Four people were hospitalized with measles-related complications during this outbreak. No deaths were reported.

VDH announces the end of this outbreak with cautious optimism. The risk of measles reintroduction remains high in the Commonwealth as measles cases continue to rise across the nation and globally. Although the local health department continues to closely monitor the areas affected by the outbreak and will rapidly respond to any suspect cases, there could be measles cases that are not known to VDH. Localities with MMR vaccination coverage rates lower than 95% are vulnerable to measles outbreaks.

During the outbreak, VDH issued outbreak-specific vaccination recommendations for the affected areas to enhance protection when the risk of exposure to measles was high in the community. Now that the outbreak has ended, these outbreak vaccination recommendations are no longer in effect for these areas.

Outbreaks such as this are good reminders of the importance of vaccination, particularly during the time of year when many families are sending their children back to school.

Despite the outbreak ending, VDH encourages all clinicians across the Commonwealth to:

  • Ensure your patients are up to date on routinely recommended MMR vaccinations for children and adults.
  • Encourage your patients who will be travelling internationally or to an outbreak area to consider measles in their travel plans, including an early dose for infants 6–11 months.
  • Maintain a high index of suspicion for measles in patients presenting with fever and rash, especially in those who are unvaccinated.
  • Immediately report suspected or confirmed measles cases to your local health department. Please do not wait for laboratory confirmation.
  • Check the immune status of the healthcare providers on your teams and take readiness steps for your facility.
  • Visit VDH’s Measles Information for Healthcare Providers website for the latest information about measles in Virginia.

VDH Remains Committed to Vaccines and School Required Immunizations

On August 11, 2026, in response to a recent Presidential Executive Order, VDH issued a news release reaffirming our commitment to vaccines as an essential tool in protecting the health of children, their families, and their communities.

The Presidential Executive Order does not change our vaccine recommendations or school immunization requirements in Virginia. VDH continues to recommend that children are vaccinated in accordance with the American Academy of Pediatrics (AAP) 2026 Child and Adolescent Immunization Schedule. VDH expects that healthcare providers will continue to rely on their clinical training and professional judgment and consult information published by AAP and the American Academy of Family Physicians when engaging in shared clinical decision-making with parents, caregivers, and patients.

Virginia is already taking action to evaluate and protect access to vaccines. Pursuant to Item 278 M1, Ch 1, 2026 Acts of Assembly, Special Session I, VDH will convene its newly established Workgroup on Childhood Immunization Schedules and Public Health Emergencies in late August 2026. This group will bring together key partners – including healthcare practitioners, insurance representatives, and public health stakeholders – to review Virginia’s statutory and regulatory frameworks pertaining to access to childhood and emergency immunizations. We will provide updates on the efforts of this important group as they become available.

On behalf of the entire VDH team, thank you for your partnership, dedication and determination in keeping Virginians safe and healthy.

© 2026 Medical Society of Virginia | 2924 Emerywood Parkway, Suite 300, Richmond, VA 23294 | 800-746-6768